Maciaczyk, D <br/><br/>
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.  [electronic resource] 

 -  British journal of cancer  Jun 2017 
 - 102-112 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2017.157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Blotting, Western<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Survival<br/>Computer Simulation<br/>Dacarbazine--analogs & derivatives<br/>Databases, Factual<br/>Drug Resistance, Neoplasm--genetics<br/>Epithelial-Mesenchymal Transition--genetics<br/>Glioblastoma--drug therapy<br/>Glycolysis--genetics<br/>Humans<br/>Immunoglobulin J Recombination Signal Sequence-Binding Protein--genetics<br/>Isocitrate Dehydrogenase--genetics<br/>Mutation<br/>Neoplasm Invasiveness--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Prognosis<br/>RNA, Messenger--metabolism<br/>Temozolomide<br/>Tumor Hypoxia--genetics<br/>Zinc Finger E-box-Binding Homeobox 1--metabolism